AEYE Health

Company profile

About AEYE Health

AEYE Health is a digital health company founded in 2019 in New York City that develops AI-based autonomous diagnostic screening solutions for ocular and systemic diseases using retinal imaging. The company's flagship product, AEYE-DS, is the only FDA-cleared solution offering instant AI diabetic retinopathy diagnosis with both handheld and tabletop cameras, requiring just one image per eye and delivering on-the-spot diagnostic reports in one minute without physician interpretation needed. The solution is CPT 92229 reimbursable and helps close HEDIS gaps. AEYE Health's technology platform enables screening for a broad range of diseases beyond diabetic retinopathy, including glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), and systemic conditions like cardiovascular disease, hypertension, and dementia. Their Aurora AEYE product is the first and only FDA-cleared AI-powered diabetic retinopathy solution for portable cameras, achieving 92-93% sensitivity and 89-94% specificity with over 99% success rate. The company's mission is to make screening for ocular diseases more accessible and help prevent blindness, particularly in underserved communities. By enabling primary care physicians to conduct point-of-care screening, AEYE Health replaces the traditional specialist referral process, addressing the diabetic retinopathy care gap where less than 50% of US patients with diabetes adhere to annual eye exams. The company serves primary care practices, endocrinologists, and teleretinal screening services across the United States.

Company description · AEYE Health official website